رجوع
31
نطاق اليوم
KWD 33.38
KWD 34.76
نطاق 52 أسبوعًا
KWD 22.66
KWD 55.00
حجم التداول
306,431
متوسط 50 يوم / 200 يوم
KWD 42.59
/
KWD 35.79
الإغلاق السابق
KWD 34.31
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 763.0 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | 0.2 | 3.7 |
| Net Margin % | 0.2 | 3.9 |
| Rev Growth 5Y % | 1.2 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 55.250
+60.3%
Low: KWD 49.000
High: KWD 60.000
مكرر الربحية المستقبلي
19.6
ربحية السهم المستقبلية
KWD 1.751
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.2 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 2.530
KWD 2.471 – KWD 2.580
|
1.4 B | 1 |
| FY2027 |
KWD 2.088
KWD 1.817 – KWD 2.493
|
1.3 B | 6 |
| FY2026 |
KWD 1.751
KWD 1.671 – KWD 1.852
|
1.2 B | 6 |
النقاط الرئيسية
Revenue grew 1.15% annually over 5 years — modest growth
Earnings declined -83.62% over the past year
ROE of 0.17% is below average
Debt/Equity of 0.17 — conservative balance sheet
Generating 86.89M in free cash flow
P/E of 763.02 — premium valuation
النمو
Revenue Growth (5Y)
1.15%
Revenue (1Y)6.53%
Earnings (1Y)-83.62%
FCF Growth (3Y)-21.11%
الجودة
Return on Equity
0.17%
ROIC0.27%
Net Margin0.17%
Op. Margin0.44%
الأمان
Debt / Equity
0.17
Current Ratio1.43
Interest Coverage0.84
التقييم
P/E Ratio
763.02
P/B Ratio1.27
EV/EBITDA304.95
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.53% | Revenue Growth (3Y) | 1.63% |
| Earnings Growth (1Y) | -83.62% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1.15% | Earnings Growth (5Y) | -59.71% |
| Profitability | |||
| Revenue (TTM) | 1.18B | Net Income (TTM) | 2.05M |
| ROE | 0.17% | ROA | 0.10% |
| Gross Margin | 42.49% | Operating Margin | 0.44% |
| Net Margin | 0.17% | Free Cash Flow (TTM) | 86.89M |
| ROIC | 0.27% | FCF Growth (3Y) | -21.11% |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 1.43 |
| Interest Coverage | 0.84 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 763.02 | P/B Ratio | 1.27 |
| P/S Ratio | 1.32 | PEG Ratio | -12.16 |
| EV/EBITDA | 304.95 | Dividend Yield | 0.00% |
| Market Cap | 1.57B | Enterprise Value | 1.57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.18B | 1.11B | 1.15B | 1.30B | 1.13B |
| Net Income | 2.05M | 12.53M | -20.37M | 5.65M | 77.85M |
| EPS (Diluted) | 0.04 | 0.27 | -0.45 | 0.12 | 1.62 |
| Gross Profit | 503.44M | 471.00M | 499.93M | 588.99M | 554.65M |
| Operating Income | 5.16M | 337,000.0 | -19.33M | -2.32M | 89.51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.97B | 2.12B | 2.23B | 2.21B | 2.14B |
| Total Liabilities | 742.91M | 877.65M | 1.04B | 1.08B | 995.81M |
| Shareholders' Equity | 1.23B | 1.24B | 1.19B | 1.13B | 1.15B |
| Total Debt | 204.35M | 382.55M | 614.09M | 616.74M | 541.01M |
| Cash & Equivalents | 196.52M | 369.20M | 467.97M | 330.36M | 349.05M |
| Current Assets | 680.07M | 815.49M | 927.57M | 881.81M | 780.70M |
| Current Liabilities | 476.61M | 595.68M | 367.79M | 428.45M | 876.16M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#817 of 1052
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026